HBICE platform

Harbour BioMed Clears Regulatory Milestone for HBM7004

CAMBRIDGE, Massachusetts; ROTTERDAM, Netherlands; SHANGHAI, China, June 10, 2026 Harbour BioMed announced that the National Medical Products Administration (NMPA)...

By cGxPwire Editor
June 10, 2026

.Clinical

Harbour BioMed Receives FDA IND Clearance for HBM7004 Solid Tumor Trial

CAMBRIDGE, Massachusetts, ROTTERDAM, Netherlands, and SHANGHAI, China, May 8, 2026 Harbour BioMed announced that the U.S. Food and Drug...

By cGxPwire Editor
May 9, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

HBICE platform

Harbour BioMed Clears Regulatory Milestone for HBM7004

Harbour BioMed Receives FDA IND Clearance for HBM7004 Solid Tumor Trial